Aripiprazole

Generic Name: aripiprazole

Atypical Antipsychotic [EPC]Over-the-Counter (OTC)

Brand Names:

Aripiprazole

Aripiprazole is an atypical antipsychotic medication available as orally disintegrating tablets.

Overview

Aripiprazole is an atypical antipsychotic medication available as orally disintegrating tablets.

Uses

Indicated for treatment of schizophrenia in adults and adolescents (13-17 years), irritability associated with autistic disorder in children and adolescents (6-17 years), and Tourette's disorder.

Dosage

For schizophrenia in adults: initial dose 10-15 mg/day, recommended 10-15 mg/day, maximum 30 mg/day. For adolescents (13-17 years): initial 2 mg/day, target 10 mg/day, maximum 30 mg/day. For autistic disorder (6-17 years): initial 2 mg/day, target 5-10 mg/day, maximum 15 mg/day.

Side Effects

Common adverse reactions in adults include nausea, vomiting, constipation, headache, dizziness, akathisia, anxiety, insomnia, and restlessness. In pediatric patients: somnolence, headache, vomiting, extrapyramidal disorder, fatigue, increased appetite, insomnia, nausea, and weight increase.

Warnings

Elderly patients with dementia-related psychosis treated with antipsychotic drugs face increased risk of death. Aripiprazole is not approved for dementia-related psychosis. Increased risk of suicidal thinking in children, adolescents, and young adults. Monitor closely for worsening and emergence of suicidal thoughts.

Frequently Asked Questions

What is Aripiprazole used for?

Indicated for treatment of schizophrenia in adults and adolescents (13-17 years), irritability associated with autistic disorder in children and adolescents (6-17 years), and Tourette's disorder.

What are the side effects of Aripiprazole?

Common adverse reactions in adults include nausea, vomiting, constipation, headache, dizziness, akathisia, anxiety, insomnia, and restlessness. In pediatric patients: somnolence, headache, vomiting, extrapyramidal disorder, fatigue, increased appetite, insomnia, nausea, and weight increase.

What are the important warnings for Aripiprazole?

Elderly patients with dementia-related psychosis treated with antipsychotic drugs face increased risk of death. Aripiprazole is not approved for dementia-related psychosis. Increased risk of suicidal thinking in children, adolescents, and young adults. Monitor closely for worsening and emergence of suicidal thoughts.

Related Medications

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.